Literature DB >> 1947811

Cutaneous manifestations of Lyme borreliosis. Clinical definitions and differential diagnoses.

E Asbrink1.   

Abstract

At the IVth international Conference on Lyme borreliosis the cutaneous manifestations and differential diagnoses were reviewed. Erythema migrans (EM) is a spontaneously healing erythematous lesion occuring at the site of borrelial inoculation. Typically it is homogeneous or is annular with centrifugal spreading. Atypical variants may also occur. Borrelial lymphocytoma (BL) generally presents as a bluish-red nodule. Histologically there is a dense polyclonal lymphocytic infiltrate. Predilection sites are the ear and the breast. It may appear secondarily to EM or be the first manifestation of Lyme borreliosis. EM and BL are early, localized cutaneous manifestations, but sometimes extracutaneous signs or symptoms of disseminated disease may appear simultaneously with either of these lesions. Multiple EM-like lesions, occurring as a result of hematogenous spread, are the cutaneous markers of disseminated disease. Acrodermatitis chronica atrophicans is a chronic skin lesion which is generally seen on the extremities. It starts with an inflammatory phase with bluish-red discoloration, which years to decades later may be followed by an atrophic phase. Sclerotic skin lesions may also develop. Important differential diagnoses are granuloma annulare, malignant lymphoma, benign lymphoreticular infiltrations and sclerotic lesions of non-borrelial origin, collagenoses and circulatory insufficiency.

Entities:  

Mesh:

Year:  1991        PMID: 1947811

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  7 in total

1.  [Lyme borreliosis].

Authors:  P Herzer; V Fingerle; H-W Pfister; A Krause
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

Review 2.  Lyme disease in the United Kingdom.

Authors:  S O'Connell
Journal:  BMJ       Date:  1995-02-04

3.  Clinical appearance of erythema migrans caused by Borrelia afzelii and Borrelia garinii--effect of the patient's sex.

Authors:  Louise Bennet; Carl-Johan Fraenkel; Ulf Garpmo; Anders Halling; Mikael Ingman; Katharina Ornstein; Louise Stjernberg; Johan Berglund
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

Review 4.  Borrelial lymphocytoma.

Authors:  Vera Maraspin; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2022-08-09       Impact factor: 2.275

5.  Characterization of Finnish Borrelia burgdorferi sensu lato isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and with monoclonal antibodies.

Authors:  J Tuomi; L K Rantamäki; R Tanskanen; J Junttila
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis.

Authors:  L V von Stedingk; I Olsson; H S Hanson; E Asbrink; A Hovmark
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

7.  Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans.

Authors:  P D Mitchell; K D Reed; T L Aspeslet; M F Vandermause; J W Melski
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.